G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses

다국어 초록 (Multilingual Abstract)

Leucine rich-repeat kinase 2 (LRRK2) is involved in the pathogenesis of Parkinson’s disease (PD).
LRRK2 has kinase and GTPase activities, and mediates several cell functions, including vesicle trafficking, apoptosis, autophagy, mitochondrial dynamics, and neuroinflammation. G2019S (GS) is the most prevalent mutation of LRRK2. The mutation increases kinase activity, suggesting that this activity is crucial for PD pathogenesis. The activation and inhibition of LRRK2 kinase increases and reduces the levels of proinflammatory cytokines, respectively suggesting that the role of LRRK2 in neuroinflammation is critical for the pathology of PD. Previously, we demonstrated that microglial activation by lipopolysaccharide (LPS) increases mitochondrial fission via the activation of LRRK2 kinase, while LRRK2 kinase inhibition diminishes the fission morphology and release of tumor necrosis factor-alpha (TNFα) in BV2 or rat primary microglia and the brains of GS transgenic mice. In this study, the ectopic expression of GS LRRK2 in BV2 cells significantly elevated the expression of Drp1 along the fragmented mitochondria and decreased mitochondria size compared with controls. GS LRRK2-transfected BV2 cells displayed significantly increased TNFα release and neuronal death. Inhibition of LRRK2 kinase alleviated these features. TNFα levels in brains of GS mice were significantly increased compared to those in their littermates. These data further support our previous findings concerning LPS-induced neuroinflammation and mitochondrial fission in microglia via LRRK2 kinase activation.

참고문헌 (Reference)

1 Kondo K, "alpha-synuclein aggregation and transmission are enhanced by leucine-rich repeat kinase 2 in human neuroblastoma SH-SY5Y cells" 34 : 1078-1083, 2011

2 Lewis PA, "The R1441C mutation of LRRK2 disrupts GTP hydrolysis" 357 : 668-671, 2007

3 Saez-Atienzar S, "The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells : involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling" 5 : e1368-, 2014

4 Dzamko N, "The IkappaB kinase Family Phosphorylates the Parkinson’s disease kinase LRRK2 at Ser935 and Ser910 during Toll-like Receptor signaling" 7 : e39132-, 2012

5 Liu G, "Selective expression of Parkinson’s disease-related Leucine-rich repeat kinase 2G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression" 24 : 5299-5312, 2015

6 Ho DH, "Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor alphamediated neurotoxicity" 482 : 1088-1094, 2017

7 Mendivil-Perez M, "Neuroprotective effect of the LRRK2 kinase inhibitor PF-06447475 in human nerve-like differentiated cells exposed to oxidative stress stimuli : implications for Parkinson’s disease" 41 : 2675-2692, 2016

8 Khan NL, "Mutations in the gene LRRK2 encoding dardarin(PARK8)cause familial Parkinson’s disease : clinical, pathological, olfactory and functional imaging and genetic data" 128 : 2786-2796, 2005

9 Yang S, "Mitochondrial dysfunction driven by the LRRK2-mediated pathway is associated with loss of Purkinje cells and motor coordination deficits in diabetic rat model" 5 : e1217-, 2014

10 Park J, "Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells" 127 : 221-232, 2013

11 Park J, "Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-kappaB pathways" 584 : 191-196, 2015

12 Puccini JM, "Leucinerich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders" 35 : 5271-5283, 2015

13 Niu J, "Leucine-rich repeat kinase 2disturbs mitochondrial dynamics via Dynamin-like protein" 122 : 650-658, 2012

14 Ho DH, "Leucine-Rich repeat kinase 2(LRRK2)phosphorylates p53 and induces p21(WAF1/CIP1)expression" 8 : 54-, 2015

15 Heo HY, "LRRK2enhances oxidative stress-induced neurotoxicity via its kinase activity" 316 : 649-656, 2010

16 Wang X, "LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1" 21 : 1931-1944, 2012

17 Bae E-J, "LRRK2 kinase regulates α-synuclein propagation via RAB35phosphorylation" 9 : 3465-, 2018

18 Marker DF, "LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein" 9 : 261-261, 2012

19 Yang D, "LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model : suppression by curcumin" 47 : 385-392, 2012

20 호동환, "LRRK2 Kinase Activity Induces Mitochondrial Fission in Microglia via Drp1 and Modulates Neuroinflammation" 한국뇌신경과학회 27 (27): 171-180, 2018

21 Greggio E, "Kinase activity is required for the toxic effects of mutant LRRK2/dardarin" 23 : 329-341, 2006

22 장지훈, "Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity" 한국통합생물학회 22 (22): 273-280, 2018

23 Ramonet D, "Dopaminergic neuronal loss, reduced neurite complexity and Autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2" 6 : e18568-, 2011